Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Focusing of Light in the Eye01:16

Focusing of Light in the Eye

Light rays enter the eye through the cornea, a transparent dome-shaped tissue that is the eye's outermost layer. The cornea bends or refracts, light rays traveling to the pupil. The shape of the cornea determines how much of the light is bent and whether the image will be focused correctly on the retina at the back of the eye. Once the light has passed through both refraction layers, it converges into a single focal point onto a small area. This is where photoreceptors start transforming...
Angle Closure Glaucoma: Treatment01:28

Angle Closure Glaucoma: Treatment

Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
Open Angle Glaucoma: Treatment01:27

Open Angle Glaucoma: Treatment

In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Glaucoma: Overview01:25

Glaucoma: Overview

Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Accuracy of six contemporary toric formulas: Analysis of 6,753 Eyes.

Journal of cataract and refractive surgery·2026
Same author

Large Language Models for Rapid Instrument Prototyping: Design and Structural Optimization of the Dry Eye Disease in Pregnancy Questionnaire (DED-PREG).

Clinical ophthalmology (Auckland, N.Z.)·2026
Same author

The Science of Pseudoaccommodation and Its Therapeutic Potential.

Clinical ophthalmology (Auckland, N.Z.)·2026
Same author

Current Trends in Presbyopia Correction-A Comprehensive Review.

Journal of clinical medicine·2026
Same author

Using Large Language Models for In Silico Development and Simulation of a Patient-Reported Outcome Questionnaire for Cataract Surgery with Various Intraocular Lenses: A Pre-Validation Study.

Journal of clinical medicine·2026
Same author

Impact of Intraocular Lens Design on Refractive Endpoint Selection: A Call for a New Paradigm.

Clinical ophthalmology (Auckland, N.Z.)·2025
Same journal

Efficacy of Punctal Occlusion Techniques in Tear Drainage Disorders: A Systematic Review and Meta-Analysis.

Clinical ophthalmology (Auckland, N.Z.)·2026
Same journal

Discontinuing Anti-VEGF Therapy in Patients with Neovascular Age-Related Macular Degeneration That Remains Inactive with Treatment at the Maximum Injection Interval.

Clinical ophthalmology (Auckland, N.Z.)·2026
Same journal

Ophthalmic Implications of Ehlers-Danlos Syndrome.

Clinical ophthalmology (Auckland, N.Z.)·2026
Same journal

Diagnostic Value of Pupil Involvement and Yield of Vascular Imaging in Isolated Third Cranial Nerve Palsy: A 10-Year Retrospective Study.

Clinical ophthalmology (Auckland, N.Z.)·2026
Same journal

Short-Term Preliminary Results of Outcomes with and without Tenonectomy During Open Conjunctival XEN45 Gel Stent Implantation.

Clinical ophthalmology (Auckland, N.Z.)·2026
Same journal

Chemical and Thermal Ocular Burns in Children: A Retrospective Single-Center Study of Etiology, Clinical Characteristics, and Outcomes.

Clinical ophthalmology (Auckland, N.Z.)·2026
See all related articles

Related Experiment Video

Updated: May 16, 2026

Correction of Presbyopia by Monocular Bi-Aspheric Ablation Profile
05:46

Correction of Presbyopia by Monocular Bi-Aspheric Ablation Profile

Published on: September 20, 2024

Visual Outcomes with Enhanced Monofocal and Non-Diffractive Extended Depth-of-Field Intraocular Lenses.

Jakub Poliński1,2, Dorota Walasik-Szemplińska2, Joanna Sempińska-Szewczyk1

  • 1Department of Ophthalmology, National Medical Institute of the Ministry of the Interior and Administration, Warsaw, Poland.

Clinical Ophthalmology (Auckland, N.Z.)
|May 15, 2026
PubMed
Summary
This summary is machine-generated.

The AcrySof IQ Vivity extended depth-of-field (EDOF) intraocular lens (IOL) offers the widest visual range, but with reduced contrast sensitivity. The RayOne enhanced monofocal IOL provides improved intermediate vision and comparable contrast sensitivity to standard monofocal IOLs.

Keywords:
EDOF IOLcataractenhanced monofocal IOLpresbyopia

More Related Videos

Rotating the Intraocular Lens to Prevent Posterior Capsular Opacification in Cataract Surgeries
04:59

Rotating the Intraocular Lens to Prevent Posterior Capsular Opacification in Cataract Surgeries

Published on: July 7, 2023

Related Experiment Videos

Last Updated: May 16, 2026

Correction of Presbyopia by Monocular Bi-Aspheric Ablation Profile
05:46

Correction of Presbyopia by Monocular Bi-Aspheric Ablation Profile

Published on: September 20, 2024

Rotating the Intraocular Lens to Prevent Posterior Capsular Opacification in Cataract Surgeries
04:59

Rotating the Intraocular Lens to Prevent Posterior Capsular Opacification in Cataract Surgeries

Published on: July 7, 2023

Area of Science:

  • Ophthalmology
  • Biomedical Engineering
  • Optics

Background:

  • Cataract surgery aims to restore vision using intraocular lenses (IOLs).
  • Advancements include enhanced monofocal and extended depth-of-field (EDOF) IOLs to improve visual quality.
  • Direct comparison of these IOLs is crucial for clinical decision-making.

Purpose of the Study:

  • To compare visual acuity and quality of vision.
  • Evaluate outcomes between an enhanced monofocal IOL (RayOne EMV), an EDOF IOL (AcrySof IQ Vivity), and a standard monofocal IOL (RayOne Aspheric).

Main Methods:

  • Single-center cohort study of bilateral cataract surgery patients.
  • Groups implanted with RayOne EMV, AcrySof IQ Vivity, or RayOne Aspheric IOLs.
  • Assessed distance, intermediate, and near visual acuities, defocus curves, contrast sensitivity, and patient-reported outcomes.

Main Results:

  • Corrected distance visual acuity was similar across all groups.
  • Vivity showed superior intermediate and near acuity compared to EMV and monofocal.
  • EMV demonstrated better intermediate acuity than monofocal; contrast sensitivity was lower with Vivity.
  • Vivity achieved higher spectacle independence, while EMV reported fewer "bothersome" visual symptoms.

Conclusions:

  • The Vivity IOL offers the broadest visual range, including near tasks, but compromises contrast sensitivity.
  • The RayOne EMV IOL effectively bridges monofocal and EDOF technologies, enhancing intermediate vision with good contrast sensitivity and safety.
  • Both advanced IOLs show promise in improving visual outcomes post-cataract surgery.